REGISTER NOW with only 9 days to go !
Don't miss hearing the experts : Amyloidosis 2017
A new era in diagnosis and management
Professor Philip Hawkins, Director UK National Amyloidosis Centre
University College London & Professor Rodney Falk, Director Cardiac Amyloidosis Programme Brigham & Women's Hospital, Boston, Harvard University
Register at
www.agf.org.au/amyloidosis-2017/
Only 2 weeks to go !
Don't miss hearing the experts : Amyloidosis 2017
A new era in diagnosis and management
Register now
Only 4 weeks to go !
Don't miss hearing the experts : Amyloidosis 2017
A new era in diagnosis and management
The patient and family programme is aimed at providing practical information on advances in the treatment of each of the amyloidosis disorders. It will provide an opportunity to ask questions of the experts. Most exciting is the chance to hear first hand the insights and knowledge of two world leaders in amyloidosis, Professors Philip Hawkins from University College, Londonand Rodney Falk from Harvard University, Boston.
10.20 – 10.50am WELCOMING COFFEE
Session 1 10.50am – 12.20pm
Chair : Patricia Neely
10.50 -11.00 What is amyloidosis?
Peter Mollee
11.00 -11.20 What are the different types of amyloid diseases
Graeme Stewart
11.20 – 12.00 Amyloidosis of the Heart
Rodney Falk
12.00 – 1.00pm Are we close to a cure for amyloidosis?
Philip Hawkins
12.20 – 1.00pm LUNCH
Session 2 1.00pm – 3.00pm
Chair : Linda Mekhael
1.00 – 1.10 pm The importance of education and community awareness of
amyloidosis
Patricia Neely
1.10 – 1.20pm A personal perspective on fighting for a cure for all people with
amyloidosis
Trisha Gardiner
1.20 – 3.00pm Interactive session based on questions submitted by attendees
similar in format to the Westmead Forum in May 2016 with the
goal of covering all recent advances in each form of amyloid
disease including familial amyloidosis.
3.00pm WORKSHOP CLOSURE
Preliminary Programmes
Saturday 11 February 2017
Loewenthal Auditorium, Westmead Education Centre
1. Clinical & Scientific Programme
The clinical and scientific programme is aimed at providing practical updates on diagnosis and management (including major advances in disease-modifying treatment) of each of the major amyloidosis disorders, predominantly AL, AA and ATTR – familial and wild type.
Recent advances are particularly relevant to cardiologists but also of importance to clinicians across all of the fields affected by amyloid disease
Plenary Session 1 Advances in diagnosis 8.30-10.20am
Chair : Graeme Stewart
8.30am Introduction and Welcome
8.40am What is amyloidosis ?
Peter Mollee
8.50am The spectrum and prevalence of the amyloid diseases
Fiona Kwok
9.00am How to diagnose and type amyloidosis
Philip Hawkins
9.40am How to diagnose cardiac amyloidosis
Rodney Falk
10.20 – 10.50am COFFEE BREAK
Plenary Session 2 Brief updates 10.50am – 12.20pm
Chair : Fiona Kwok
10.50am Amyloid L disease
Simon Gibbs
11.00am Autoinflammation and Amyloid A disease
Ming-Wei Lin
11.10am Detection of amyloidogenic genetic mutations
David Booth
11.20 amFamilial amyloidosis : carrier detection and prophylaxis
Graeme Stewart
11.30am Amyloid neuropathies
Steve Vucic
12.00pm Renal amyloidosis
Richard Phoon
12.10pm Cardiac amyloidosis : the Westmead experience
Liza Thomas
12.20 – 1.00pm LUNCH
Plenary Session 3 Advances in management 1.00 – 2.20pm
Chair : Peter Mollee
1.00pm Cardiac amyloidosis
Rodney Falk
1.40pm Non-cardiac amyloidosis
Philip Hawkins
Parallel Session 1 Cardiac Amyloidosis 2.30 – 3.40pm
Case-based interactive session with Rodney Falk
Chair : Liza Thomas
Designed to assist specialists involved in the diagnosis and management of cardiac amyloidosis in understanding the varied clinical presentations and in meeting the diagnostic and treatment challenges in 2017.
2.30 – 3.30pmSix selected case presentations and discussions aimed at
highlighting the many difficulties and traps encountered
in the specialised amyloidosis centres
3.30 – 3.40pmSummary and final questions
Philip Hawkins
Parallel Session 2 Non-cardiac Amyloidosis 2.30 – 2.30pm
Case-based interactive session with Philip Hawkins
Chair : Ming-Wei Lin
Designed to assist specialists in Tissue Pathology, Medical Imaging (MRI, Nuclear Medicine, PET), Haematology, Rheumatology, Immunology, Genetic Medicine, Neurology and Renal Medicine in understanding the varied clinical presentation and prevalence and in meeting the diagnostic and treatment challenges in the range of amyloidosis disorders in 2017.
2.30 – 3.30pm Case presentations and discussions selected to highlight
the many difficulties and traps encountered in the specialised
amyloidosis centres
3.30 – 3.40pmSummary and final questions
Philip Hawkins
3.40 – 4.10pm COFFEE BREAK
Plenary Session 4 Future directions 4.10 – 4.50pm
Chair : Simon Gibbs
4.10 – 4.30pm How close is a cure for amyloidosis ? Scientific breakthrough
and planned clinical trials
Philip Hawkins
4.30-4.50pm Final questions and discussion
Philip Hawkins and Rodney Falk
4.50pm WORKSHOP CLOSE
Adam Gardiner Fund INC. would like to thank Jenny & Michael who took part in this year's
Bowral Classic Bike Race
Jenny & Michael nominated to raise funds & awareness for AGF INC. & Amyloidosis
We are very proud and honoured
We would like to wish Jenny & Michael the best of luck at the Bowral Classic 2016
Thank you for all your support
www.bowralclassic.gofundraise.com.au/page/JennyAndrich0
CONGRATULATIONS
Kobe Thorson
who won The Adam Gardiner Memorial Award
for S.G Ball Balmain Tigers Best Forward
HURRY FINAL TWO WEEKS TO GET YOUR TICKETS FOR THIS YEARS AGF RACE DAY WE HAVE ONLY 18 TICKETS AVAILABLE !
DON'T MISS OUT
#AGFINC
